Biotech firm Maze Therapeutics, backed by Third Rock Ventures, revealed a profit for the first nine months of 2024 in its ...

The main difference between going public through an initial public offering (IPO) and staying private lies in ownership ...

The issue received bids of 9,18,47,850 shares against the offered 57,99,999 equity shares, at a price band of ₹275-290, ...

AirBaltic continues to work on plans for an initial public offering (IPO), which is now set to take place in the spring of ...

Quadrant Future Tek IPO receives overwhelming response, closes Thursday with price band of ₹275-290, funds for long-term ...

Spanish travel technology firm HBX Group is considering announcing plans for an initial public offering as early as next week ...

Maze Therapeutics has filed for an initial public offering with the Securities and Exchange Commission. The San Francisco-based human genetics biotech company didn't say Tuesday how many shares it ...

A biopharmaceutical company and its executives misled investors ahead of its 2024 initial public offering about a key ...

Drug developer Maze Therapeutics Inc.'s rollercoaster ride is leading to the Bay Area's first biotech IPO filing of 2025.

Indobell Insulation’s IPO, worth ₹10.14 crore, was fully subscribed on its first day. The offering is priced at ₹46 per share ...

The initial public offering (IPO) of Quadrant Future Tek Limited has officially opened today, January 7, 2025, to positive ...

(Reuters) -Oilfield services provider Flowco Holdings on Tuesday said it is seeking a valuation of up to $2 billion in its ...